""L’hôpital construit par Horta" : c’est par ce signe distinctif que l’on désigne souvent le site initial du CHU Brugmann. Son architecture pavillonnaire, son parc de 18 hectares aux allures de jardin arboré, étonnent dans le paysage hospitalier bruxellois. Dès son inauguration, en 1923, l’hôpital a cultivé l’art d’innover. Plusieurs premières médicales, dont la première greffe cardiaque belge, y ont vu le jour. Une tradition qui se perpétue dans la recherche de pointe, et des services novateurs..."

During the past decade, CHU Brugmann (Victor Horta) conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Brugmann (Victor Horta)" #1 collaborator was "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CHU Brugmann (Victor Horta)" are "Geographic Atrophy" (3 trials), "Rheumatoid Arthritis" (2 trials), "Anemia" (1 trials), "Breast Cancer" (1 trials) and "Lymphoma, Large B-Cell, Diffuse" (1 trials). Many other conditions were trialed in "CHU Brugmann (Victor Horta)" in a lesser frequency.

Most popular intervention types in "CHU Brugmann (Victor Horta)" are "Drug" (9 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lampalizumab" (3 trials), "Placebo" (2 trials), "CHOP" (1 trials), "Leflunomide" (1 trials) and "Letrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Brugmann (Victor Horta)" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CHU Brugmann (Victor Horta)". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CHU Brugmann (Victor Horta), undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Brugmann (Victor Horta), 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".